TORONTO, ONTARIO: Cynapsus-sponsored study suggests significant market potential for APL 130277, the Company's sublingual Apomorphine drug candidate for Parkinson's disease
...
PARIS: Basil Strategies Announces the 2nd Edition of Doctors 2.0(TM) & You, the Conference (Paris, May 23-24, 2012); This Year Will Focus on Emerging Trends in Health Care Social Media Communities, Tools ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.